
    
      This study is an exploratory phase II clinical study with no sample size estimation.According
      to the results of the preliminary animal experiments and phase I clinical trials, 2
      concentrations (0.002% and 0.004%ZKY001eye drops) were selected as the experimental group,
      and 1 placebo control group was selected, with 35 subjects in each group and a total of 105
      subjects.Each subject will drop the study drug into the test eye (the surgical eye is taken
      as the test eye) according to the randomly assigned drug number.
    
  